HC Wainwright & Co. Reiterates Buy on Gritstone Bio, Maintains $7 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Sean Lee has reiterated a Buy rating on Gritstone Bio (NASDAQ:GRTS) and maintained a $7 price target.
March 06, 2024 | 1:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Sean Lee reiterates a Buy rating on Gritstone Bio with a $7 price target.
The reiteration of a Buy rating and maintenance of a $7 price target by a reputable analyst could positively influence investor sentiment towards GRTS, potentially driving its stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100